| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.69B | -1.6% |
| Cost of Revenue | $2.72B | -3.4% |
| Gross Profit | $978.0M | +3.8% |
| R&D Expense | $45.0M | +2.3% |
| SG&A Expense | $429.0M | -0.2% |
| Pre-tax Income | $451.0M | +14.8% |
| Income Tax | $99.0M | +4.2% |
| Net Income | $352.0M | +18.1% |
| EPS (Basic) | $1.68 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $137.0M | +19.1% |
| Accounts Receivable | $337.0M | -2.9% |
| Inventory | $567.0M | +8.2% |
| Current Assets | $1.10B | +5.8% |
| Total Assets | $4.87B | +1.9% |
| Current Liabilities | $539.0M | +12.8% |
| Long-term Debt | $1.69B | -8.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $489.0M | -24.1% |
| Capital Expenditures | $120.0M | +15.4% |
| Investing Cash Flow | -$120.0M | -9.1% |
| Financing Cash Flow | -$346.0M | +24.3% |
| Free Cash Flow | $369.0M | -31.7% |
| +18.3% |
| EPS (Diluted) | $1.67 | +17.6% |
| Total Liabilities |
| $2.73B |
| -2.4% |
| Stockholders' Equity | $2.14B | +8.0% |